We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GLAD:NASDAQGladstone Capital Corporation Analysis

Data as of 2026-06-13 - not real-time

$19.39

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Gladstone Capital (GLAD) trades at $19.39, comfortably above its recent support of $18.64 but below the 30‑day DCF fair value of $30.01, implying a potential upside of roughly 13 %. The stock’s P/E of 10.4 is well under the industry average of 16.8, and the price‑to‑book of 0.91 suggests a discount to net asset value, supporting an undervalued view. However, the dividend yield is exceptionally high at 9.5 % while the payout ratio exceeds 100 %, and operating cash flow is negative, raising concerns about the sustainability of the dividend. Technical indicators are mixed: RSI sits at 53 (neutral), the MACD histogram is slightly negative with a bearish signal, and volume trends are decreasing, indicating limited short‑term momentum. Recent material news includes a Zacks Rank upgrade to a “Buy,” which could attract income‑focused investors ahead of the upcoming ex‑dividend date on June 23.
Risk factors are notable: 30‑day volatility is around 25 %, the max drawdown exceeds 43 %, and the company carries $392 M of debt against just $3.4 M of cash, yielding a high debt‑to‑equity ratio. Nonetheless, beta is low (≈0.58), suggesting limited market‑wide risk, and the sector—financial services/asset management—exhibits medium risk. Balancing the attractive valuation and dividend against cash‑flow weakness and leverage leads to a cautious but optimistic stance for medium‑term investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with bearish MACD signal
  • High dividend yield but questionable sustainability
  • Decreasing trading volume limiting short‑term momentum

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to DCF fair value and industry multiples
  • Attractive dividend yield for income investors
  • Zacks Rank upgrade signaling improved earnings expectations

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Elevated leverage and negative operating cash flow
  • Potential dividend cuts if cash generation does not improve
  • Stable sector exposure with low beta reducing market risk

Key Metrics & Analysis

Financial Health

Revenue Growth20.50%
Profit Margin44.05%
P/E Ratio10.4
ROE8.40%
ROA5.18%
Debt/Equity75.84
P/B Ratio0.9
Op. Cash Flow$-93471000
Free Cash Flow$34.9M
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI53.2
Support$18.64
Resistance$19.65
MA 20$19.23
MA 50$18.98
MA 200$20.02
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value$30.01
Target Price$22.00
Upside/Downside13.46%
GradeUndervalued
TypeValue
Dividend Yield9.52%

Risk Assessment

Beta0.58
Volatility25.24%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.